Australia's most trusted
source of pharma news
Monday, 11 May 2026
Monday, 11 May 2026
Subscribe
Login
'Slow to respond' CSL nosedives
CSL's share price fell to the lowest in a decade as it cut its financial forecast for the year - with the boss conceding the company had been slow to respond to competitive pressures in key markets.
Patient advocate named Governor
Tasmania has tapped a former nurse who worked for 18 years as CEO of a high-profile patient group as their next Governor
TODAY
Who's opening in Waterloo?
Sydney's first purpose-built commercial life sciences precinct already has three companies on board ahead of opening in 2028
TODAY
Novo's obesity pill hits the TGA
Novo Nordisk has revealed its obesity pill which is taking the US by storm could be heading Down Under
8 May
$135M market under threat
Exclusivity of four drugs is at risk after a judge allowed the patent term extension protecting them to be challenged
7 May
Industry's 'Most Influential' named
A single Big Pharma has made this year's prestigious TIME100 Most Influential Companies list for a first-to-market win
7 May
Aussie class action targets pharma
Law firm continues to assess a "significant number" of enquiries and registrations from people who have used these drugs
6 May
Latest Jobs
Business Development ManagerSpecialty Pharmaceutical Sales RepresentativeSurgical Sales SpecialistSurgical Sales SpecialistWarehouse AssistantPharmacy AssistantSenior Recruitment ConsultantRegional Quality Head23 more...
Pharma in Focus Jobs
Marketing & Communications (7)
- Trade Marketing Manager - Sydney
- Product Manager - New South Wales
- Internal Communications Specialist - Melbourne
- Trade Marketing Manager - Sydney
- Senior Product Manager - Sydney
- Associate Marketing Manager - OTC - Sydney
- Senior Data & Insights Analyst - Melbourne
Sales & Customer Relations (9)
- Business Development Manager - Sydney
- Specialty Pharmaceutical Sales Representative - Queensland
- Surgical Sales Specialist - Auckland
- Surgical Sales Specialist - Auckland
- Customer Service Team Leader - Frenchs Forest
- Territory Manager - Melbourne
- Territory Manager - Surgical - Sydney
- Pharmaceutical Sales Representative - Sydney
- Account Manager - Sydney
Clinical & Medical, R&D (4)
- Senior Medical Manager - Melbourne
- Senior Medical Science Liaison - Melbourne
- Clinical Trial Start Up Specialist - Melbourne
- Clinical Project Manager - Oncology - Sydney, NSW
Regulatory, Pharmacovigilance & QA (4)
- Regional Quality Head - Sydney
- Regulatory Submissions Specialist - Melbourne
- QA Specialist - Melbourne
- Senior Regulatory Affairs Associate - Sydney
Other (8)
PBAC July Agenda blows out to 58
Eight submissions have been added to version 3 of the PBAC's July meeting agenda, hiking the total number to almost 60
TODAY
Three companies add new drugs
TGA approves three new products plus a subcutaneous version of AstraZeneca's monoclonal antibody and a first-ever generic
TODAY Approvals Action
Company scoops top gong... again
For the fourth year in a row, and for the fifth time overall, customers have named this chain the Pharmacy of the Year
8 May
Onboarding failures drive quitting
ICYMI: Aussie pharma's newest talent heading for the exit. Find out why plus the other most popular stories this week
8 May Your Week in 5 Minutes
Company snaps up ex-MA exec
After almost five years with Medicines Australia, this senior executive has returned to a Big Pharma role
8 May
Lilly unveils Vivid health vision
To mark its 150th Anniversary, Lilly Australia has entered an industry-first partnership with the iconic Vivid Sydney light show
8 May
Sweet upside for obesity drugs
Bracing for fallout from booming GLP-1 uptake, chocolate manufacturers have instead been delivered a surprise windfall
7 May
Troubled drug faces new drama
After 8 deaths the FDA is now investigating whether data for a major drug was manipulated, and the TGA is paying attention
7 May
Industry's global jobs purge ongoing
While Australia is in the clear, the one-time darling of the pandemic plus two other companies trim their OS workforces
7 May
Look who's opening a US office
With growing demand from global pharma for its AI commercialisation platform, this Aussie company is setting up in Boston
6 May
Who's hit a 25-year milestone?
An idea jotted on the back of a cafe napkin plus a healthy dose of ambition, has seen this company grow into a great Aussie success story
6 May
Bridge Program spans a decade
Collaboration between Australian pharma companies, universities and industry affiliates has celebrated its 10th year
6 May
Board wipeout hits local company
In less than a month an activist investor has won the resignation of a CEO and changed the entire board of this company
6 May
Lilly GM confirms drug launch
Newly approved treatment soon to roll out on private script with Aussie boss acknowledging the "significant challenges" in securing subsidy
5 May